Komori
Financial results presentation6988NITTO DENKO CORPORATIONMaterials and Chemicals

Fiscal Year Ending March 2026 Earnings Summary [IFRS] (Consolidated) Earnings Presentation Materials

In fiscal 2025, revenue and profit increased in Industrial Tape and Human Life, while Optoronics reported lower revenue and profit and the stronger yen had an adverse impact. As a result, overall revenue increased but profit declined. In fiscal 2026, revenue, operating profit and net profit are expected to increase. The annual dividend is also planned to increase to ¥64, and the Company plans to repurchase ¥50 billion of its own shares.

Worth reading
73In focus
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
-21
¥100 million (year-on-year change in operating profit)
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial results presentationFull fiscal year ending March 2026 (fiscal 2025)10 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales10,282 Hundreds of millions of yen+1.4%
Operating profit1,836 Hundreds of millions of yen-1.1%
Ordinary income¥1,850 100 million -0.2%profit before tax
Net income¥1,335 100 million -2.7%profit for the year attributable to owners of the parent
Operating profit margin17.9 %
Results for the three months of the current quarter
Revenue
2,420 Hundreds of millions of yen
Operating profit
358 Hundreds of millions of yen
Income before taxes
363 Hundreds of millions of yen
Profit for the period attributable to owners of the parent
278 Hundreds of millions of yen
Operating profit margin
14.8 %
Full-year earnings forecast
Revenue
10,650 Hundreds of millions of yen
Operating profit
1,930 Hundreds of millions of yen
Income before taxes
1,930 Hundreds of millions of yen
Profit for the period attributable to owners of the parent
1,410 Hundreds of millions of yen
Operating profit margin
18.1 %
ROE
12 %
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Fiscal 2025 full-year year-on-year change in operating profit
Selling prices, purchase prices and rationalization0
Sales volume variance165
Fixed Costs-160
Royalties-25
Special factors, product mix and other factors40
Other40
Foreign Exchange Effects-81
Fiscal 2025 Q4 year-on-year change in operating profit
Selling prices, purchase prices and rationalization-5
Sales volume variance-190
Fixed Costs-176
Royalties10
Special factors, product mix and other factors0
Other22
Foreign Exchange Effects17
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
  • U.S. dollar exchange rate¥153
New initiatives
  • Increase the annual dividend by ¥4 to ¥64 in fiscal 2026
  • Plan to repurchase ¥50 billion of the Company's own shares from April to August 2026
  • Capital expenditures are expected to total ¥120 billion and research and development expenses ¥50 billion in fiscal 2026
Key KPIsA metric the company considers important as a management benchmark.
  • ROE12.2 %
    Year on year against the same period last year-1.3%
  • U.S. dollar exchange rate¥150.2
    Year on year against the same period last year-2.7%
Segment results
Industrial Tape
Revenue
3,666 Hundreds of millions of yen
Operating profit
517 Hundreds of millions of yen
Revenue_yoy_pct4.2
Operating profit_yoy_pct12.6
Optoronics
Revenue
5,278 Hundreds of millions of yen
Operating profit
1,499 Hundreds of millions of yen
Revenue_yoy_pct-2.6
Operating profit_yoy_pct-13.4
Human Life
Revenue
1,437 Hundreds of millions of yen
Operating profit
-50 Hundreds of millions of yen
Revenue_yoy_pct8.5
Other
Revenue
0 Hundreds of millions of yen
Operating profit
-70 Hundreds of millions of yen
Revenue_yoy_pct-40.6
Adjustments
Revenue
-100 Hundreds of millions of yen
Operating profit
-59 Hundreds of millions of yen
Financial targets
ROE
FY2025 actual12.2 %
FY2026 forecast12 %
Capital expenditures
¥868 100 million FY2025 actual
Fiscal 2026 outlook
1,200 Hundreds of millions of yen
Annual Dividend
Annual Dividend
¥64
Payout ratio
30.7 %
Total payout ratio
66.2 %
Acquisition of treasury shares
Amount
500 Hundreds of millions of yen
PeriodApril to August 2026
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredFull fiscal year ending March 2026 (fiscal 2025)
Net Sales10,282 Hundreds of millions of yen (YoY +1.4%)
Operating profit1,836 Hundreds of millions of yen (YoY -1.1%)
Ordinary income¥1,850 100 million (profit before tax) (YoY -0.2%)
Net income¥1,335 100 million (profit for the year attributable to owners of the parent) (YoY -2.7%)
Operating profit margin17.9 %
Results for the three months of the current quarterRevenue 2,420 Hundreds of millions of yen / Operating profit 358 Hundreds of millions of yen / Income before taxes 363 Hundreds of millions of yen / Profit for the period attributable to owners of the parent 278 Hundreds of millions of yen / Operating profit margin 14.8 %
Full-year earnings forecastRevenue 10,650 Hundreds of millions of yen / Operating profit 1,930 Hundreds of millions of yen / Income before taxes 1,930 Hundreds of millions of yen / Profit for the period attributable to owners of the parent 1,410 Hundreds of millions of yen / Operating profit margin 18.1 % / ROE 12 %
Segment resultsIndustrial Tape Revenue 3,666 Hundreds of millions of yen / Operating profit 517 Hundreds of millions of yen / Revenue_yoy_pct 4.2 / Operating profit_yoy_pct 12.6 / Optoronics Revenue 5,278 Hundreds of millions of yen / Operating profit 1,499 Hundreds of millions of yen / Revenue_yoy_pct -2.6 / Operating profit_yoy_pct -13.4 / Human Life Revenue 1,437 Hundreds of millions of yen / Operating profit -50 Hundreds of millions of yen / Revenue_yoy_pct 8.5 / Operating profit_yoy_pct Not disclosed / Other Revenue 0 Hundreds of millions of yen / Operating profit -70 Hundreds of millions of yen / Revenue_yoy_pct -40.6 / Adjustments Revenue -100 Hundreds of millions of yen / Operating profit -59 Hundreds of millions of yen
Breakdown of Factors Affecting the ChangeFiscal 2025 full-year year-on-year change in operating profit Selling prices, purchase prices and rationalization 0 / Sales volume variance 165 / Fixed Costs -160 / Royalties -25 / Special factors, product mix and other factors 40 / Other 40 / Foreign Exchange Effects -81 / Fiscal 2025 Q4 year-on-year change in operating profit Selling prices, purchase prices and rationalization -5 / Sales volume variance -190 / Fixed Costs -176 / Royalties 10 / Special factors, product mix and other factors 0 / Other 22 / Foreign Exchange Effects 17
Key KPIsIndicator name ROE / Value 12.2 % / Year on year against the same period last year -1.3 %, Indicator name U.S. dollar exchange rate / Value ¥150.2 / Year on year against the same period last year ¥-2.7
Assumptions Underlying the Business OutlookIndicator name U.S. dollar exchange rate / Value ¥153
Financial targetsROE FY2025 actual 12.2 % / FY2026 forecast 12 %
Annual DividendAnnual Dividend ¥64 / Interim Dividend Not disclosed / Year-end dividend Not disclosed
Payout ratio30.7 %
Acquisition of treasury sharesAmount 500 Hundreds of millions of yen / Period April to August 2026 / Number of Shares Not disclosed
Capital expenditures¥868 100 million (FY2025 actual)
New initiativesIncrease the annual dividend by ¥4 to ¥64 in fiscal 2026, Plan to repurchase ¥50 billion of the Company's own shares from April to August 2026, Capital expenditures are expected to total ¥120 billion and research and development expenses ¥50 billion in fiscal 2026
Items this document does not state (12)
Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Industrial Tape and Human Life reported higher revenue, but Optoronics, the core business, reported lower revenue, resulting in higher revenue but lower profit overall. Operating profit was adversely affected by ¥8.1 billion from foreign exchange movements; excluding this impact, both revenue and profit increased.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Fiscal Year Ending March 2026 Earnings Summary [IFRS] (Consolidated) Earnings Presentation Materials | NITTO DENKO CORPORATION (6988) timely disclosure | Komori